A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis
Authors:
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 20 (4) , 467-473
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancersJournal of Clinical Pathology, 2007
- Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate CancerCancer Research, 2006
- TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate CancerCancer Research, 2006
- Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with RearrangementNeoplasia, 2006
- Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancerGenes, Chromosomes and Cancer, 2006
- Transcription factors in cancerEuropean Journal of Cancer, 2005
- ETS transcription factors and their emerging roles in human cancerEuropean Journal of Cancer, 2005
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- The Retinoic Acid Synthesis GeneALDH1a2Is a Candidate Tumor Suppressor in Prostate CancerCancer Research, 2005
- Cloning of the TMPRSS2 Gene, Which Encodes a Novel Serine Protease with Transmembrane, LDLRA, and SRCR Domains and Maps to 21q22.3Genomics, 1997